Preliminary results have been obtained on the second phase of the
clinical trials for the Normogen preparation.
Stabilization of the tumor process with positive dynamics was
observed for 80% of the patients who have various types of
cancerous diseases.
Report of Kazakhstan Scientific and Research
Institute of Oncology and Radiology
of the 1st phase of clinical trial of
immunobiological, antitumoral drug Normogen
Real Med Company can offer different variants of cooperation,
in particular such as
1. Sale of exclusive and non-exclusive licenses for use and/or production of the "Normogen" drug;
2. Joint marketing programs.
